Author:
de la Caridad Addine Ramírez Bárbara,Marrón Reynel,Calero Rommel,Mirabal Mayelin,Ramírez Juan Carlos,Sarmiento María E,Norazmi Mohd Nor,Acosta Armando
Abstract
Abstract
An in silico study was carried out to identify antigens for their possible collective use as vaccine candidates against diseases caused by different classes of pathogenic mycobacteria with significant clinical relevance. The genome sequences of the relevant causative agents were used in order to search for orthologous genes among them. Bioinformatics tools permitted us to identify several conserved sequences with 100% identity with no possibility of cross-reactivity to the normal flora and human proteins. Nine different proteins were characterized using the strain H37Rv as reference and taking into account their functional category, their in vivo expression and subcellular location. T and B cell epitopes were identified in the selected sequences. Theoretical prediction of population coverage was calculated for individual epitopes as well as their combinations. Several identical sequences, belonging to six proteins containing T and B cell epitopes which are not present in selected microorganisms of the normal microbial flora or in human proteins were obtained.
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Smith I: Mycobacterium tuberculosis Pathogenesis and Molecular Determinants of Virulence. Clin. Microbiol. Rev. 2003, 16 (3): 463-496. 10.1128/CMR.16.3.463-496.2003.
2. Martín C, Bigi F, Gicquel B: New Vaccines against Tuberculosis. Tuberculosis 2007: From basic science to patient care. 2007, 341-360. First
3. Vargas García R: Epidemiología de las micobacteriosis atípicas en la salud humana. BNF Emerge. 2008, 2 (4): 220-230.
4. Marcel AB: Mycobacterium du jour: what's on tomorrow's menu?. Microbes and Infection. 2008, 10 (9): 968-972. 10.1016/j.micinf.2008.07.001.
5. Young DB, Perkins MD, Duncan K, Barry CE: Confronting the scientific obstacles to global control of tuberculosis. J Clin Invest. 2008, 118 (4): 1255-65. 10.1172/JCI34614.